Epigenetic Silencing of Cyclooxygenase-2 Affects Clinical Outcome in Gastric Cancer
Michiel F.G. de Maat(Leiden University Medical Center), Dave S.�B. Hoon(Saint John's Health Center), Cornelis J.�H. van de Velde(Leiden University Medical Center), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Naoyuki Umetani(JR Tokyo General Hospital), Pieter de Heer(Copenhagen University Hospital), Anneke Q. van Hoesel(Leiden University Medical Center), Peter J.K. Kuppen(Leiden University Medical Center), Hein Putter, Gerrit A. Meijer(The Netherlands Cancer Institute), Nicole C.T. van Grieken(Cancer Center Amsterdam), Anton J. Bilchik(Saint John's Health Center)
Cited by 62
Related Papers
Gastric cancer
|The Lancet|2020|4.8k
Persistent epigenetic differences associated with prenatal exposure to famine in humans
|Proceedings of the National Academy of Sciences|2008|3k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k